AAAAAA
Results:
1-14
|
Results: 14
Authors:
Lagrange, JL
Ramaioli, A
Theodore, C
Terrier-Lacombe, MJ
Beckendorf, V
Biron, P
Chevreau, C
Chinet-Charrot, P
Dumont, J
Delobel-Deroide, A
D'Anjou, J
Chassagne, C
Parache, RM
Karsenty, JM
Mercier, J
Droz, JP
Citation: Jl. Lagrange et al., Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patientstreated in the French anticancer centres, ANN ONCOL, 12(9), 2001, pp. 1313-1319
Authors:
Fizazi, K
Amato, RJ
Beuzeboc, P
Petit, N
Bouhour, D
Thiss, A
Rebischung, C
Chevreau, C
Logothetis, CJ
Droz, JP
Citation: K. Fizazi et al., Germ cell tumors in patients infected by the human immunodeficiency virus, CANCER, 92(6), 2001, pp. 1460-1467
Authors:
Rols, MP
Bachaud, JM
Giraud, P
Chevreau, C
Roche, H
Teissie, J
Citation: Mp. Rols et al., Electrochemotherapy of cutaneous metastases in malignant melanoma, MELANOMA RE, 10(5), 2000, pp. 468-474
Authors:
Chatelut, E
Pivot, X
Otto, J
Chevreau, C
Thyss, A
Renee, N
Milano, G
Canal, P
Citation: E. Chatelut et al., A limited sampling strategy for determining carboplatin AUC and monitoringdrug dosage, EUR J CANC, 36(2), 2000, pp. 264-269
Authors:
Negrier, S
Fervers, B
Bailly, C
Beckendorf, V
Cupissol, D
Dore, JF
Garbay, JR
Vilmer, C
Borel, C
Boulier, N
Cabarrot, E
Carrie, C
Chevreau, C
de Cislain, C
Delaunay, MM
Depardieu, C
Dubois, JB
Escande, MC
Fraisse, J
Parache, RM
Philip, T
Ravaud, A
Sancho-Garnier, H
Spatz, A
Autier, P
Bonnetblanc, JM
de Raucourt, S
Dreno, B
Gouttebel, MC
Grange, F
Guillot, B
Khayat, D
Lehmann, M
Leroy, D
Regal, R
Revuz, J
Saiag, P
Schmutz, JL
Truchetet, F
Vuillemin, P
Citation: S. Negrier et al., Standards, options and guidelines for caring for patients with cutaneous melanomas, PRESSE MED, 29(23), 2000, pp. 1317-1326
Authors:
Bastit, P
Chevallier, B
Chevreau, C
Mihura, J
Roche, H
Namer, M
Gedouin, D
Kerbrat, P
Lesimple, T
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Luporsi, E
Rios, M
Weber, B
Bremond, A
Devaux, Y
Monteuquet, P
Schraub, S
Hayat, M
Zambon, E
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Chollet, P
Van Praagh, I
Cattan, A
Eymard, JC
Pourny, C
Facchini, T
Walter, S
Dides, S
Ramos, R
Guiochet, N
Seffert, P
Perpoint, X
Sztermer, JF
Cretin, J
Goudier, MJ
Morice, F
Delecroix, V
Fumoleau, P
Citation: P. Bastit et al., Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment, J CL ONCOL, 18(17), 2000, pp. 3115-3124
Authors:
Delannes, M
Thomas, L
Martel, P
Bonnevialle, P
Stoeckle, E
Chevreau, C
Bui, BN
Daly-Schveitzer, N
Pigneux, J
Kantor, G
Citation: M. Delannes et al., Low-dose-rate intraoperative brachytherapy combined with external beam irradiation in the conservative treatment of soft tissue sarcoma, INT J RAD O, 47(1), 2000, pp. 165-169
Authors:
Malavaud, B
Mazerolles, C
Bieth, E
Chevreau, C
Le Frere, MA
Alric, L
Citation: B. Malavaud et al., Pure seminoma in a male phenotype 46,XX true hermaphrodite, J UROL, 164(1), 2000, pp. 125-126
Authors:
Bachaud, JM
Berthier, F
Soulie, M
Malavaud, B
Plante, P
Rischmann, P
Chevreau, C
Grosclaude, P
Citation: Jm. Bachaud et al., Risk of second non-germ-cell cancer after treatment of a stage I-II testicular seminoma, PROG UROL, 9(4), 1999, pp. 689-695
Authors:
Ray-Coquard, I
Le Cesne, A
Rubio, MT
Mermet, J
Maugard, C
Ravaud, A
Chevreau, C
Sebban, C
Bachelot, T
Biron, P
Blay, JY
Citation: I. Ray-coquard et al., Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens, J CL ONCOL, 17(9), 1999, pp. 2840-2846
Authors:
Escudier, B
Chevreau, C
Lasset, C
Douillard, JY
Ravaud, A
Fabbro, M
Caty, A
Rossi, JF
Viens, P
Bergerat, JP
Savary, J
Negrier, S
Citation: B. Escudier et al., Cytokines in metastatic renal cell carcinoma: Is it useful to switch to interleukin-2 or interferon after failure of a first treatment?, J CL ONCOL, 17(7), 1999, pp. 2039-2043
Authors:
Chevreau, C
Bui, BN
Chevallier, B
Krakowski, I
Maugard, C
Mihura, J
Coindre, JM
Gil, B
Cour-Chabernaud, V
Citation: C. Chevreau et al., Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS), AM J CL ONC, 22(3), 1999, pp. 267-272
Authors:
Bachaud, JM
Berthier, F
Soulie, M
Malavaud, B
Plante, P
Rischmann, P
Chevreau, C
Daly-Schveitzer, N
Grosclaude, P
Citation: Jm. Bachaud et al., Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma, RADIOTH ONC, 50(2), 1999, pp. 191-197
Authors:
Dorval, T
Negrier, S
Chevreau, C
Avril, MF
Baume, D
Cupissol, D
Oskam, R
de Peuter, R
Vinke, J
Herrera, L
Escudier, B
Citation: T. Dorval et al., Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma, CANCER, 85(5), 1999, pp. 1060-1066
Risultati:
1-14
|